Last Updated: November 8, 2026

Details for New Drug Application (NDA): 074815

NDA 074815 describes ALPROSTADIL, which is a drug marketed by Hikma and Meitheal and is included in two NDAs. It is available from one supplier. Additional details are available on the ALPROSTADIL profile page.

The generic ingredient in ALPROSTADIL is alprostadil. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the alprostadil profile page.

Summary for 074815

Tradename:	ALPROSTADIL
Applicant:	Hikma
Ingredient:	alprostadil
Patents:	0

Medical Subject Heading (MeSH) Categories for 074815

Platelet Aggregation Inhibitors
Urological Agents
Vasodilator Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	0.5MG/ML
Approval Date:	Jan 20, 1998	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.